Volume 19, Number 5—May 2013
CME ACTIVITY - Research
Transmission of Mycobacterium tuberculosis Beijing Strains, Alberta, Canada, 1991–2007
Table 2
Characteristic | All cases | No. (%) clustered cases | OR (95% CI)* |
|
---|---|---|---|---|
Unadjusted | Adjusted† | |||
Beijing | ||||
Sex | ||||
F | 100 | 19 (19.0) | 1.0 | |
M | 158 | 36 (22.8) | 1.3 (0.7–2.3) | |
Age at diagnosis, y | ||||
<35 | 72 | 17 (23.6) | 1.0 | 1.0 |
35–64 | 69 | 19 (27.5) | 1.2 (0.6–2.6) | 1.3 (0.6–2.8) |
>64 | 117 | 19 (16.2) | 0.6 (0.3–1.3) | 0.7 (0.3–1.5) |
Population group | ||||
Canadian-born | 19 | 7 (36.8) | 1.0 | |
Foreign-born, other | 26 | 6 (23.1) | 0.5 (0.1–1.9) | |
Foreign-born, Western Pacific | 213 | 42 (19.7) | 0.4 (0.2–1.1) | |
Sputum smear status | ||||
Negative | 132 | 26 (19.7) | 1.0 | |
Positive | 112 | 25 (22.3) | 1.2 (0.6–2.2) | |
Bacillary load | ||||
Low | 38 | 7 (18.4) | 1.0 | |
High | 16 | 6 (37.5) | 2.7 (0.7–9.8) | |
Chest radiography | ||||
No cavitation | 206 | 40 (19.4) | 1.0 | 1.0 |
Cavitation | 52 | 15 (28.8) | 1.7 (0.8–3.4) | 1.6 (0.8–3.2) |
Drug resistance | ||||
Pan-susceptible | 202 | 42 (20.8) | 1.0 | |
Monoresistance | 30 | 7 (23.3) | 1.2 (0.5–2.9) | |
Polyresistance | 20 | 6 (30.0) | 1.6 (0.6–4.5) | |
Multidrug resistance |
6 |
0 |
NA |
|
Non-Beijing | ||||
Sex | ||||
F | 492 | 168 (34.1) | 1.0 | 1.0 |
M | 629 | 250 (39.7) | 1.3 (0.98–1.6) | 1.1 (0.8, 1.4) |
Age at diagnosis, y | ||||
<35 | 319 | 134 (42.0) | 1.0 | 1.0 |
35–64 | 421 | 182 (43.2) | 1.1 (0.8–1.4) | 0.8 (0.5–1.1) |
>64 | 381 | 102 (26.8) | 0.5 (0.4–0.7) | 0.4 (0.3–0.6) |
Population group | ||||
Canadian-born | 520 | 316 (60.8) | 1.0 | 1.0 |
Foreign-born, other | 346 | 42 (12.1) | 0. 1 (0.06–0.13) | 0.09 (0.06–0.13) |
Foreign-born, Western Pacific | 255 | 60 (23.5) | 0.20 (0.14–0.28) | 0.21 (0.15–0.31) |
Sputum smear status | ||||
Negative | 517 | 198 (38.3) | 1.0 | |
Positive | 538 | 199 (37.0) | 0.9 (0.7–1.2) | |
Bacillary load | ||||
Low | 177 | 67 (37.9) | 1.0 | |
High | 89 | 39 (43.8) | 1.3 (0.8–2.1) | |
Chest radiography | ||||
No cavitation | 853 | 312 (36.6) | 1.0 | |
Cavitation | 268 | 106 (39.6) | 1.1 (0.9–1.5) | |
Drug resistance | ||||
Pan-susceptible | 1,000 | 393 (39.3) | 1.0 | 1.0 |
Monoresistance | 90 | 19 (21.1) | 0.4 (0.2–0.7) | 0.6 (0.4–1.1) |
Polyresistance | 25 | 5 (20.0) | 0.4 (0.1–1.04) | 0.7 (0.3–2.1) |
Multidrug resistance | 6 | 1 (16.7) | 0.3 (0.04–2.7) | 0.5 (0.05–5.0) |
*Boldface indicates significance (p<0.05). OR, odds ratio.
†Multivariate analysis was based on purposeful selection with variables with p<0.2 in unadjusted analyses being included in the multivariate model. For Beijing strains, multivariate analysis included the independent variables of age at diagnosis and chest radiography. Sex, age at diagnosis, population group, and drug resistance were the independent variables in the multivariate analysis for non-Beijing strains.
Page created: April 25, 2013
Page updated: April 25, 2013
Page reviewed: April 25, 2013
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.